Back
ESC Professional Premium Access

Inappropriate dosing of direct oral anticoagulants in patients with atrial fibrillation undergoing percutaneous coronary intervention

Session: Oral anticoagulant therapy for atrial fibrillation in clinical practice
Topic: Oral Anticoagulation
Speaker: Doctor H. Kitahara (Chiba, JP)
Event: ESC Congress 2024

Congress Presentation

Add to my library

Like

About the speaker

Doctor Hideki Kitahara

Chiba University Graduate School of Medicine, Chiba (Japan)
0 follower

7 more presentations in this session

Temporal trends of prescription rates, dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in patients with atrial fibrillation

Speaker: Doctor T. Chao (Taipei, TW)

Access
Abstract
Slides
Video
Like
Thumbnail

Persistence and predictors for non-persistence to edoxaban therapy in patients with atrial fibrillation: 4-year follow-up data from the ETNA-AF-Europe study

Speaker: Associate Professor I. Diemberger (Bologna, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Impact of resumption of Oral AntiCoagulation therapy (OAC) after GastroIntestinal Bleeding (GIB) on clinical outcomes in patients with Non-Valvular Atrial Fibrillation (NVAF)

Speaker: Doctor W. Sun (Shatin, HK)

Access
Abstract
Slides
Video
Like
Thumbnail

The efficacy and safety of NOAC in very elderly atrial fibrillation patients; data from the Korean national health insurance cohort registry

Speaker: Doctor S. Choi (Incheon, KR)

Access
Abstract
Slides
Video
Like
Thumbnail

Impact of body weight and body mass index on clinical outcomes of edoxaban therapy in atrial fibrillation patients included in the ETNA-AF-Global registry

Speaker: Professor G. Boriani (Modena, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Oral anticoagulant therapy for atrial fibrillation in clinical practice

Speakers: Doctor H. Kitahara, Doctor T. Chao, Associate Professor I. Diemberger, Doctor W. Sun, Doctor S. Choi...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources